---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-009051"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2022-04-04T23:59:59+00:00"
generated_at: "2026-06-26T10:03:37.269775+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Oncotelic issues $0.25M convertible note to Fourth Man, LLC at 12% interest

## Summary
- Convertible promissory note principal $0.25M, 12% annual interest, matures in one year.
- Conversion price fixed at $0.10 per share; also issued 1,250,000 warrants at $0.20 exercise.
- Finder's fee to JH Darbie: 10% of gross proceeds plus warrants equal to 10% of amount raised.
- Proceeds for general working capital and repayment of certain debt; same terms as November 2021 issuances.

## SEC filing metadata
- accession: 0001493152-22-009051
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2022-04-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315222009051/0001493152-22-009051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315222009051/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-009051
- JSON: https://secwatch.observer/filing/0001493152-22-009051.json
- Plain text: https://secwatch.observer/filing/0001493152-22-009051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.